September 10, 2025
OXFORD, UK and CLEVELAND, Ohio, US, 10 September 2025 – The Oxford-Harrington Rare Disease Centre (‘OHC’), a partnership between the University of Oxford, UK and Harrington Discovery Institute at University Hospitals, Cleveland, Ohio, dedicated to creating new medicines for rare diseases, announces that Lord...
Continue ReadingJune 24, 2025
Harrington Discovery Institute and the American Society for Clinical Investigation seek nominations to recognize an outstanding achievement by a physician-scientist Continue Reading
June 03, 2025
Drug development grant will advance 10 physician-scientists’ discoveries toward the clinic Continue Reading
May 23, 2025
Scientific researchers and leaders from across the globe gathered in Cleveland, Ohio to discuss progress being made in drug development for a variety of conditions, including Alzheimer’s and rare diseases. Continue Reading
May 01, 2025
Call for proposals on proteostasis and senescence are particularly encouraged, alongside all novel approaches to treating Alzheimer’s disease Continue Reading
April 29, 2025
Mr. Jafar is a distinguished international business leader and co-founder of the Loulou Foundation Continue Reading
April 16, 2025
Unique program for physician-scientists to advance promising discoveries into medicines Continue Reading
March 19, 2025
2025 Harrington Prize for Innovation in Medicine recognizes groundbreaking contributions in the creation of targeted cancer therapies Continue Reading
February 18, 2025
Renowned US Neuroscientist and Harvard Professor brings extensive expertise in academia and industry to advance rare disease research Continue Reading
February 05, 2025
Award highlights collaboration between for profit and non-profit achieving great impact Continue Reading
January 15, 2025
Scholar Award Accelerates Novel Therapies for Rare Diseases Continue Reading